Some brands never cut consumers a break. Apple, for example, is notoriously tight-fisted when it comes to discounts. Internet-connected speaker company Sonos is another member of that camp.
But today on Amazon, Prime members can get a crack at Sonos’ PLAY:3 smart speaker for nearly 15% off. That’s a great deal if we’ve ever heard of one. (Not a Prime member? Get a 30-day free trial here.)
A Wi-Fi-connected speaker that lets you stream music from more than 30 online sources (including Spotify, Apple Music, Pandora, TuneIn, your own personal library and more), the PLAY:3 is a versatile little sound system. You can prop it up, lay it flat, mount it on the wall, or even use a pair as rear channel surround sound speakers. Or, if you have multiple Sonos speakers, you can sprinkle them throughout your home to create a whole-house audio system without dealing with a bunch of in-wall wiring.
Sonos owners gush over their gear for two reasons in particular. The first is the sound quality — the PLAY:3 speaker has a tweeter and two subwoofers, making music sound great from the high end to deep bass. Second, through Sonos’ heady “Trueplay” software, the PLAY:3 pairs with the mic on your smartphone to sonically map the room in which it’s placed, then customizes its sound to that space. And Sonos constantly updates its speakers’ software, which helps prevent them from going obsolete. (For instance, that Trueplay concept was released around four years after the PLAY:3 was first made available.)
“Ah,” you’re likely saying, “but Sonos can’t make their products voice controllable.” Not so, says the company, which recently demoed a yet-to-be-released Amazon Alexa integration. That’s slated for release sometime in 2017.
In the meantime, it would be smart to hop on this deal. Typically $299, the PLAY:3 is currently available to Amazon Prime customers for $256. I wish I could say it was “available for a song,” but you don’t get great-sounding speakers for nothing.
More Must-Read Stories From TIME
- How an Online Pharmacy Sold Millions Worth Of Dubious COVID-19 Drugs — While Patients Paid the Price
- Why Literally Millions of Americans Are Quitting Their Jobs
- Meet the Women Participating in the Study That Could Change Future of Breast Cancer
- Inside the Battle for the Hearts and Minds of Tomorrow's Business Leaders
- An Innovative Washington Law Aims to Get Foreign-Trained Doctors Back in Hospitals
- Why the Ex-Husband of a Missing Chinese Billionaire Is Risking All to Tell Their Story
- Timothée Chalamet Wants You to Wear Your Heart on Your Sleeve